GBP/USD 1.360 EUR/GBP 0.862 GBP/JPY 199.387 EUR/USD 1.172 GBP/AUD 2.082 USD/JPY 146.626 USD/CAD 1.368 AUD/USD 0.653 CAD/JPY 107.148 EUR/CAD 1.603 GBP/CAD 1.861 AUD/CAD 0.894 AUD/JPY 95.775 AUD/NZD 1.088 EUR/AUD 1.794 GBP/USD 1.360 EUR/GBP 0.862 GBP/JPY 199.387 EUR/USD 1.172 GBP/AUD 2.082 USD/JPY 146.626 USD/CAD 1.368 AUD/USD 0.653 CAD/JPY 107.148 EUR/CAD 1.603 GBP/CAD 1.861 AUD/CAD 0.894 AUD/JPY 95.775 AUD/NZD 1.088 EUR/AUD 1.794
CURRENCY .wiki

Finance News – Pharmaceutical

What is your interest today?

MarketWatch Top Stories • Jun 23, 2025

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

The termination of the collaboration between Hims & Hers and Novo Nordisk triggered a substantial decline in Hims & Hers’ share value, reflecting investor concerns about the compan...

Read Full Article →
Quartz • Jun 16, 2025

A $250 mistake seems set to cost Ozempic maker Novo Nordisk billions

Novo Nordisk is expected to face substantial financial losses as Canada prepares to introduce generic alternatives of its weight loss medication due to the company’s failure to mai...

Read Full Article →
Euronews Business • May 16, 2025

Novo Nordisk CEO steps down amid growing competition for weight loss drugs

The departure of the longstanding CEO coincides with increased market challenges in the weight management sector, potentially impacting the company's strategic direction and future...

Read Full Article →
CNBC Business • May 16, 2025

Novo Nordisk CEO to step down as Wegovy maker faces growing competition

The departure of the CEO at the Danish pharmaceutical company is expected to impact investor confidence as the firm navigates increased market rivalry and aims to sustain its finan...

Read Full Article →
Quartz • May 06, 2025

Trump says pharmaceutical tariffs are coming. Here's what to expect

The introduction of new tariffs on pharmaceutical products could potentially impact medication prices and affect the costs faced by both manufacturers and consumers in the healthca...

Read Full Article →
CNBC Business • Apr 30, 2025

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom

Pharmaceutical companies are responding to potential tariff concerns by increasing their manufacturing investments in the U.S., indicating a strategic shift in their financial plan...

Read Full Article →